Advertisement

Coronaviruses pp 365-370 | Cite as

Electrocardiographic Changes Following Rabbit Coronavirus-Induced Myocarditis and Dilated Cardiomyopathy

  • Lorraine K. Alexander
  • Bruce W. Keene
  • J. David Small
  • Boyd YountJr.
  • Ralph S. Baric
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 342)

Abstract

Rabbit Coronavirus (RbCV) infection was divided into two phases based upon day of death and pathologic findings. During the acute phase (days 2–5) heart weights (HW) and heart weight-to-body weight (HW/BW) ratios were increased with striking dilation of the right ventricle. These changes as well as increased dilation of the left ventricle were especially pronounced during the subacute phase (days 6-12). Myocytolysis, pulmonary edema, and degeneration and necrosis of myocytes, were seen during both phases. Myocarditis, pleural effusion, calcification of myocytes, and congestion in the liver and lungs were seen in the subacute phase. Electrocardiograms (ECGs) exhibited low voltage, nonspecific ST-T wave changes, sinus tachycardia, occasional ventricular and supraventricular premature complexes and 2o AV block consistent with myocarditis and heart failure. Forty-one percent of the survivors exhibited increased HW and HW/BW ratios, biventricular dilation, interstitial and replacement fibrosis, myocyte hypertrophy and myocarditis. ECGs exhibited nonspecfic ST-T wave changes, sinus arrhythmia, occasional ventricular and supraventricular premature complexes and 2o AV block. These data suggest that RbCV infection may result in viral myocarditis and heart failure with a proportion of survivors progressing into DCM.

Keywords

Sudden Cardiac Death Heart Weight Viral Myocarditis Subacute Phase Myocyte Hypertrophy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    J. Woodruff, Am J Pathol. 101:427 (1980)Google Scholar
  2. 2.
    K. Leslie, R. Blay, C. Haisch, et al, Clin Microbiol Rev. 2:191 (1989)PubMedGoogle Scholar
  3. 3.
    W. Roberts, R. Siegel, and B. McManus, Am J Cardiol. 60: 1340 (1987)PubMedCrossRefGoogle Scholar
  4. 4.
    M. Reyes, K. Ho, F. Smith, and A. Lerner, J Infect Dis. 144:232 (1981)PubMedCrossRefGoogle Scholar
  5. 5.
    A. Matsumori and C. Kawai, in: “Viral Heart Disease”, H. Bolte ed. Springer-Verlag, NY (1984)Google Scholar
  6. 6.
    S. Edwards, J. Small, J. Geratz, L. Alexander, and R. Bark, J Infect Dis. 165:134 (1992)PubMedCrossRefGoogle Scholar
  7. 7.
    L. Alexander, J. Small, S. Edwards and R. Bark, J Infect Dis. 166 (1992)Google Scholar
  8. 8.
    J. Small, L. Aurelian, R. Squire, et al, Am J Pathol. 95:709 (1979)PubMedGoogle Scholar
  9. 9.
    C. Nelson, W. Waggoner, and P Gastonguay, Am J Physiol. 207:1107 (1964)PubMedGoogle Scholar
  10. 10.
    H. Riski, and T. Hovi, J Med Virol. 6:259 (1980)PubMedCrossRefGoogle Scholar
  11. 11.
    R Murray, B. Brown, D Brian, and G. Cabric, Ann Neurol. 31:525 (1992)PubMedCrossRefGoogle Scholar
  12. 12.
    C. Kishimoto, A. Matsumori, M. Ohmae, et al, J Am Coll Cardiol 3:1461. (1984)PubMedCrossRefGoogle Scholar
  13. 13.
    R. Myerburg and A. Castellanos, in:Heart Disease. E. Brunwald ed. W.B. Saunders Company, Philadelphia (1988)Google Scholar
  14. 14.
    T. James and K. Imamura, Jpn Heart J. 22:447 (1981)PubMedCrossRefGoogle Scholar
  15. 15.
    W. Castelli et al. in:The Prevention of Sudden Cardiac Death. J. Kostis and M. Sanders, eds. Wiley-Liss, NY. (1990)Google Scholar
  16. 16.
    T. Monath, G. Kemp, C. Cropp, and F. Chandler, J Infect Dis. 138:59 (1978)PubMedCrossRefGoogle Scholar
  17. 17.
    T. Hoshino, A Matsumori, C. Kawai, and J. Imai, Jpn Circul J. 46:1305 (1982)CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Lorraine K. Alexander
    • 1
  • Bruce W. Keene
    • 2
  • J. David Small
    • 1
  • Boyd YountJr.
    • 1
  • Ralph S. Baric
    • 1
  1. 1.Program in Infectious Diseases, Department of EpidemiologyUniversity of North Carolina at Chapel HillChapel HillUSA
  2. 2.College of Veterinary MedicineNorth Carolina State UniversityRaleighUSA

Personalised recommendations